Diagnosis and treatment of endometriosis complicated with adenomyosis

doi:10.3760/cma.j.issn.1007-1245.2022.05.021

Abstract

Abstract: Endometriosis and adenomyosis are chronic, progressive, benign diseases that seriously affect patients' quality of life and are the main causes of pelvic pain and low fertility in women. With the deepening of research in recent years, great progress has been made in their pathogenesis, diagnosis, and treatment, but there are still many controversies. This article reviews the pathogenesis, clinical manifestation, diagnosis, and treatment of endometriosis complicated with adenomyosis for clinical references, but there are still many problems that have not been defined. It is believed that with the development of medical science and the deepening of research, the diagnosis and treatment of endometriosis complicated with adenomyosis will be more perfect.

Key words: Endometriosis, Adenomyosis, Diagnosis and treatment

摘要： 子宫内膜异位症和子宫腺肌病是一种严重影响患者生活质量的慢性进展性良性疾病，是导致女性盆腔疼痛和生育能力低下的主要原因。随着近年来研究的深入，其发病机制以及诊断治疗有了很大的进展，但仍然存在诸多争议。本文就子宫内膜异位症合并腺肌病的发病机制、临床表现、诊断和治疗等方面进行综述，以供临床参考，但是仍有许多问题尚未明确，相信随着医学的发展和研究的深入，子宫内膜异位症合并腺肌病的诊治会更臻完善。

关键词: 子宫内膜异位症, 子宫腺肌病, 诊治

Wang Wen, Cui Xiujuan, Tian Xiangyu. Diagnosis and treatment of endometriosis complicated with adenomyosis[J]. International Medicine and Health Guidance News, 2022, 28(5): 687-691.

王稳, 崔秀娟, 田翔宇. 子宫内膜异位症合并腺肌病的诊治进展[J]. 国际医药卫生导报, 2022, 28(5): 687-691.

References

[1] Lövkvist L, Boström P, Edlund M, et al. Age-related differences in quality of life in swedish women with endometriosis[J]. J Womens Health (Larchmt), 2016,25(6):646-653. DOI: 10.1089/jwh.2015.5403.

[2] Vannuccini S, Lazzeri L, Orlandini C, et al. Potential influence of in utero and early neonatal exposures on the later development of endometriosis[J]. Fertil Steril, 2016,105(4):997-1002. DOI: 10.1016/j.fertnstert.2015.12.127.

[3] Jeung I, Cheon K, Kim MR. Decreased cytotoxicity of peripheral and peritoneal natural killer cell in endometriosis[J]. Biomed Res Int, 2016,2016:2916070. DOI: 10.1155/2016/2916070.

[4] Krawczyk N, Banys-Paluchowski M, Schmidt D, et al. Endometriosis-associated malignancy[J]. Geburtshilfe Frauenheilkd, 2016,76(2):176-181. DOI: 10.1055/s-0035-1558239.

[5] De Graaff AA, D'Hooghe TM, Dunselman GA, et al. The significant effect of endometriosis on physical, mental and social wellbeing: results from an international cross-sectional survey[J]. Hum Reprod, 2013,28(10):2677-2685. DOI: 10.1093/humrep/det284.

[6] Klein S, D'Hooghe T, Meuleman C, Dirksen C, et al. What is the societal burden of endometriosis-associated symptoms? A prospective belgian study[J]. Reprod Biomed Online, 2014,28(1):116-124. DOI: 10.1016/j.rbmo.2013.09.020.

[7] Ferrero S, Arena E, Morando A, et al. Prevalence of newly diagnosed endometriosis in women attending the general practitioner[J]. Int J Gynaecol Obstet, 2010,110(3):203-207. DOI: 10.1016/j.ijgo.2010.03.039.

[8] Gylfason JT, Kristjansson KA, Sverrisdottir G, et al. Pelvic endometriosis diagnosed in an entire nation over 20 years[J]. Am J Epidemiol, 2010,172(3):237-243. DOI: 10.1093/aje/kwq143.

[9] Burney RO, Giudice LC. Pathogenesis and pathophysiology of endometriosis[J]. Fertil Steril, 2012,98(3):511-519. DOI: 10.1016/j.fertnstert.2012.06.029.

[10] Drăghici IM, Drăghici L, Cojocaru M, et al. The immunoprofile of interstitial cajal cells within adenomyosis/endometriosis lesions[J]. Rom J Morphol Embryol, 2015,56(1):133-138.

[11] Struble J, Reid S, Bedaiwy MA. Adenomyosis: a clinical review of a challenging gynecologic condition[J]. J Minim Invasive Gynecol, 2016,23(2):164-185. DOI: 10.1016/j.jmig.2015.09.018.

[12] García-Solares J, Donnez J, et al. Pathogenesis of uterine adenomyosis: invagination or metaplasia?[J]. Fertil Steril, 2018,109(3):371-379. DOI: 10.1016/j.fertnstert. 2017.12.030.

[13] Parente Barbosa C, Bentes De Souza AM, et al. The effect of hormones on endometriosis development[J]. Minerva Ginecol, 2011,63(4):375-386.

[14] Petraglia F, Arcuri F, de Ziegler D, et al Inflammation: a link between endometriosis and preterm birth[J]. Fertil Steril, 2012,98(1):36-40. DOI: 10.1016/j.fertnstert.2012. 04.051.

[15] Benagiano G, Brosens I, Habiba M. Structural and molecular features of the endomyometrium in endometriosis and adenomyosis[J]. Hum Reprod Update, 2014,20(3):386-402. DOI: 10.1093/humupd/dmt052.

[16] Kang S, Li SZ, Wang N, et al. Association between genetic polymorphisms in fibroblast growth factor (FGF)1 and FGF2 and risk of endometriosis and adenomyosis in Chinese women[J]. Hum Reprod, 2010,25(7):1806-1811. DOI: 10.1093/humrep/deq128.

[17] Huang PC, Tsai EM, et al. Association between phthalate exposure and glutathione S-transferase M1 polymorphism in adenomyosis, leiomyoma and endometriosis[J]. Hum Reprod, 2010,25(4):986-994. DOI: 10.1093/humrep/deq015.

[18] Morassutto C, Monasta L, Ricci G, et al. Incidence and estimated prevalence of endometriosis and adenomyosis in northeast italy: a data linkage study[J]. PLoS One, 2016,11(4):e0154227. DOI: 10.1371/journal.pone.0154227.

[19] Di Donato N, Montanari G, Benfenati A, et al. Prevalence of adenomyosis in women undergoing surgery for endometriosis[J]. Eur J Obstet Gynecol Reprod Biol, 2014,181:289-293. DOI: 10.1016/j.ejogrb.2014.08.016.

[20] Bernardi M, Lazzeri L, Perelli F, et al. Dysmenorrhea and related disorders[J]. F1000Res, 2017,6:1645. DOI: 10.12688/f1000research.11682.1.

[21] Horton J, Sterrenburg M, Lane S, et al. Reproductive, obstetric, and perinatal outcomes of women with adenomyosis and endometriosis: a systematic review and meta-analysis[J]. Hum Reprod Update, 2019,25(5):592-632. DOI: 10.1093/humupd/dmz012.

[22] Scala C, Leone Roberti Maggiore U, Racca A, et al. Influence of adenomyosis on pregnancy and perinatal outcomes in women with endometriosis[J]. Ultrasound Obstet Gynecol, 2018,52(5):666-671. DOI: 10.1002/uog.18989.

[23] Bruun MR, Arendt LH, Forman A, et al. Endometriosis and adenomyosis are associated with increased risk of preterm delivery and a small-for-gestational-age child: a systematic review and meta-analysis[J]. Acta Obstet Gynecol Scand, 2018,97(9):1073-1090. DOI: 10.1111/aogs.13364.

[24] Eisenberg VH, Arbib N, Schiff E, et al. Sonographic signs of adenomyosis are prevalent in women undergoing surgery for endometriosis and may suggest a higher risk of infertility[J]. Biomed Res Int, 2017,2017:8967803. DOI: 10.1155/2017/8967803.

[25] Hoyos LR, Benacerraf B, Puscheck EE. Imaging in endometriosis and adenomyosis[J]. Clin Obstet Gynecol, 2017,60(1):27-37. DOI: 10.1097/GRF.00000000- 00000265.

[26] Nisenblat V, Bossuyt PM, Farquhar C, et al. Imaging modalities for the non-invasive diagnosis of endometriosis[J]. Cochrane Database Syst Rev, 2016,2(2):CD009591. DOI: 10.1002/14651858.CD009591.pub2..

[27] Noventa M, Saccardi C, Litta P, et al. Ultrasound techniques in the diagnosis of deep pelvic endometriosis: algorithm based on a systematic review and meta-analysis[J]. Fertil Steril, 2015,104(2):366-383.e2. DOI: 10.1016/j.fertnstert.2015.05.002.

[28] Guerriero S, Ajossa S, Minguez JA, et al. Accuracy of transvaginal ultrasound for diagnosis of deep endometriosis in uterosacral ligaments, rectovaginal septum, vagina and bladder: systematic review and meta-analysis[J]. Ultrasound Obstet Gynecol, 2015,46(5):534-545. DOI: 10.1002/uog.15667.

[29] Di Donato N, Montanari G, Benfenati A, et al. Prevalence of adenomyosis in women undergoing surgery for endometriosis[J]. Eur J Obstet Gynecol Reprod Biol, 2014,181:289-293. DOI: 10.1016/j.ejogrb.2014.08.016.

[30] Tellum T, Nygaard S, Lieng M. Noninvasive diagnosis of adenomyosis: a structured review and meta-analysis of diagnostic accuracy in imaging[J]. J Minim Invasive Gynecol, 2020,27(2):408-418. DOI: 10.1016/j.jmig.2019.11.001.

[31] Van den Bosch T, Van Schoubroeck D. Ultrasound diagnosis of endometriosis and adenomyosis: state of the art[J]. Best Pract Res Clin Obstet Gynaecol, 2018,51:16-24. DOI: 10.1016/j.bpobgyn.2018.01.013.

[32] Dunselman GA, Vermeulen N, Becker C, et al. ESHRE guideline: management of women with endometriosis[J]. Hum Reprod, 2014,29(3):400-412. DOI: 10.1093/humrep/det457.

[33] Schindler AE. Hormonal contraceptives and endometriosis/adenomyosis[J]. Gynecol Endocrinol, 2010,26(12):851-854. DOI: 10.3109/09513590.2010. 534612.

[34] Schindler AE. Non-contraceptive benefits of hormonal contraceptives[J]. Minerva Ginecol, 2010,62(4):319-329.

[35] Vercellini P, Barbara G, Somigliana E, et al. Comparison of contraceptive ring and patch for the treatment of symptomatic endometriosis[J].Fertil Steril, 2010,93(7):2150-2161.DOI:10.1016/j.fertnstert.2009.01.071.

[36] Seracchioli R, Mabrouk M, Manuzzi L, et al. Post-operative use of oral contraceptive pills for prevention of anatomic relapse or symptom-recurrence after conservative surgery for endometriosis[J].Hum Reprod,2009,24(11):2729-2735.DOI:10.1093/humrep/dep259.

[37] Fedele L, Bianchi S, Zanconato G, et al. Use of a levonorgestrel- releasing intrauterine device in the treatment of rectovaginal endometriosis[J].Fertil Steril,2001,75(3):485-488.DOI:10.1016/s0015-0282(00)01759-3.

[38] Lockhat FB, Emenbolu JO, Konje JC. The evaluation of the effectiveness of an intrauterine-administered progestogens(levonorgestrel) on the symptomatic treatment of endometriosis and on the staging of the disease[J].Human Reprod,2004,19(1):179-184.DOI: 10.1093/humrep/deh004.

[39] 万兰,文玉华,杨慧芝.左炔诺孕酮宫内缓释系统治疗子宫腺肌症的临床研究[J].国际医药卫生导报,2015,21(20):3010-3012.DOI:10.3760/cma.j.issn.1007-1245.2015. 20.019.

[40] Vercellini P, Frontino G, De Giorgi O, et al. Comparison of a levonorgestrel- releasing intrauterine device versus expectant management after conservative surgery for symptomatic endometriosis: a pilot study[J].Fertil Steril,2003,80(2): 305-309.DOI:10.1016/s0015-0282(03)00608-3.

[41] Anpalagan A, Condous G. Is there a role for use of levonorgestrel intrauterine system in women with chronic pelvic pain?[J].J Minimal Invasive Gynecol,2008,15(6):663-666. DOI:10.1016/j.jmig.2008.07.008.

[42] 中国医师协会妇产科医师分会子宫内膜异位症专业委员会.子宫腺肌病诊治中国专家共识[J].中华妇产科杂志,2020,55(6):376-383.DOI:10.3760/cma.j.cn112141- 20200228-00150.

[43] Chao XP, Liu Y, Ji ML, et al. Malignant risk of pelvic mass after hysterectomy for adenomyosis or endometriosis[J].Medicine(Baltimore), 2020,99(15):e19712.DOI:10.1097/MD.0000000000019712.

[44] 中国医师协会妇产科医师分会子宫内膜异位症专业委员会,中华医学会妇产科学分会子宫内膜异位症协作组.子宫内膜异位症长期管理中国专家共识[J]. 中华妇产科杂志,2018,53(12):836-841.DOI:10.3760/cma.j.issn.0529- 567x.2018.12.007.

[45] 中华医学会妇产科学分会子宫内膜异位症协作组.子宫内膜异位症的诊治指南[J].中华妇产科杂志,2015,50(3):161-169.DOI:10.3760/cma.j.issn.0529-567x.2015.03.001.